eyeFlow, Inc. Obtains Colombia Approval for its Pilot Clinical Study Feb 14 Written By Julio G. Martinez-Clark Bogota, Colombia . On February 14, 2024, INVIMA, Colombia's regulatory agency, approved a...
eyeFlow, Inc. Obtains Colombia Approval for its Pilot Clinical Study Feb 14 Written By Julio G. Martinez-Clark Bogota, Colombia . On February 14, 2024, INVIMA, Colombia's regulatory agency, approved a pilot study by eyeFlow, Inc . at one research center in Barranquilla. This pilot clinical trial aims to recruit 60 subjects in Colombia and will last approximately 18 months. eyeFlow, Inc. is an emerging eye care company from Mission Viejo, California, developing a revolutionary glaucoma treatment. Glaucoma is a group of eye conditions that can result in vision loss and blindness. Source: INVIMA's Medical Device Committee, February 14, 2024 meeti ng minutes . eyeFlow Inc Colombia Clinical research in Latin America Medical device CRO in Latin America Medical device clinical trials Medtech clinical trials Early feasibility study Early-feasibility clinical trials First-in-human clinical trials First-in-human study Julio G. Martinez-Clark http://www.juliomartinezclark.com/